Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902)

PHASE4CompletedINTERVENTIONAL

Enrollment

243

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

April 9, 2015

Study Completion Date

April 9, 2015

Conditions

Pneumococcal Infection

Interventions

BIOLOGICAL

PNEUMOVAX™ 23

PNEUMOVAX™ 23 (23-Valent Pneumococcal Polysaccharide Vaccination, V110, PPV23)

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT02260882 - Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902) | Biotech Hunter | Biotech Hunter